127 related articles for article (PubMed ID: 35560016)
1. Antitumor effect of the selective hypoxia-inducible factor-1 inhibitors echinomycin and PX-478 on uterine fibroids.
Xu L; Ishikawa H; Zhou Y; Kobayashi T; Shozu M
F S Sci; 2022 May; 3(2):187-196. PubMed ID: 35560016
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.
Welsh S; Williams R; Kirkpatrick L; Paine-Murrieta G; Powis G
Mol Cancer Ther; 2004 Mar; 3(3):233-44. PubMed ID: 15026543
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012
[TBL] [Abstract][Full Text] [Related]
4. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.
Schwartz DL; Powis G; Thitai-Kumar A; He Y; Bankson J; Williams R; Lemos R; Oh J; Volgin A; Soghomonyan S; Nishii R; Alauddin M; Mukhopadhay U; Peng Z; Bornmann W; Gelovani J
Mol Cancer Ther; 2009 Apr; 8(4):947-58. PubMed ID: 19372568
[TBL] [Abstract][Full Text] [Related]
5. Effects of the hypoxia-inducible factor-1 inhibitor echinomycin on vascular endothelial growth factor production and apoptosis in human ectopic endometriotic stromal cells.
Tsuzuki T; Okada H; Shindoh H; Shimoi K; Nishigaki A; Kanzaki H
Gynecol Endocrinol; 2016; 32(4):323-8. PubMed ID: 26654708
[TBL] [Abstract][Full Text] [Related]
6. Echinomycin mitigates ocular angiogenesis by transcriptional inhibition of the hypoxia-inducible factor-1.
Plastino F; Santana-Garrido Á; Pesce NA; Aronsson M; Lardner E; Mate A; Kvanta A; Vázquez CM; André H
Exp Eye Res; 2021 May; 206():108518. PubMed ID: 33639134
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G
Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661
[TBL] [Abstract][Full Text] [Related]
8. Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model.
Hassan MH; Fouad H; Bahashwan S; Al-Hendy A
Hum Reprod; 2011 Nov; 26(11):3008-18. PubMed ID: 21896544
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic myomectomy for submucosal type 2 fibroids with cold enucleation technique and complete fibroid extraction using a double-lumen intracervical cannula.
Osorio W; Posada N; Cano J; Tamayo S; Giraldo J
Fertil Steril; 2021 Feb; 115(2):522-524. PubMed ID: 33272627
[TBL] [Abstract][Full Text] [Related]
10. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.
Jacoby JJ; Erez B; Korshunova MV; Williams RR; Furutani K; Takahashi O; Kirkpatrick L; Lippman SM; Powis G; O'Reilly MS; Herbst RS
J Thorac Oncol; 2010 Jul; 5(7):940-9. PubMed ID: 20512076
[TBL] [Abstract][Full Text] [Related]
11. Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions.
Vlaminck B; Toffoli S; Ghislain B; Demazy C; Raes M; Michiels C
FEBS J; 2007 Nov; 274(21):5533-42. PubMed ID: 17916190
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study.
Chuang TD; Ton N; Rysling S; Quintanilla D; Boos D; Khorram O
Fertil Steril; 2024 Apr; 121(4):669-678. PubMed ID: 38072367
[TBL] [Abstract][Full Text] [Related]
13. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong D; Park EJ; Stephen AG; Calvani M; Cardellina JH; Monks A; Fisher RJ; Shoemaker RH; Melillo G
Cancer Res; 2005 Oct; 65(19):9047-55. PubMed ID: 16204079
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma.
Kambayashi S; Igase M; Kobayashi K; Kimura A; Shimokawa Miyama T; Baba K; Noguchi S; Mizuno T; Okuda M
J Vet Med Sci; 2015 Nov; 77(11):1405-12. PubMed ID: 26050843
[TBL] [Abstract][Full Text] [Related]
15. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
Palayoor ST; Mitchell JB; Cerna D; Degraff W; John-Aryankalayil M; Coleman CN
Int J Cancer; 2008 Nov; 123(10):2430-7. PubMed ID: 18729192
[TBL] [Abstract][Full Text] [Related]
16. Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells.
Yonekura S; Itoh M; Okuhashi Y; Takahashi Y; Ono A; Nara N; Tohda S
Anticancer Res; 2013 Aug; 33(8):3099-103. PubMed ID: 23898065
[TBL] [Abstract][Full Text] [Related]
17. Anti-Uterine Fibroid Effect of Standardized Labisia Pumila Var. Alata Extracts In Vitro and in Human Uterine Fibroid Cancer Xenograft Model.
Zakaria N; Mohd KS; Ahmed Saeed MA; Ahmed Hassan LE; Shafaei A; Al-Suede FSR; Memon AH; Ismail Z
Asian Pac J Cancer Prev; 2020 Apr; 21(4):943-951. PubMed ID: 32334454
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
19. Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer.
Bailey CM; Liu Y; Peng G; Zhang H; He M; Sun D; Zheng P; Liu Y; Wang Y
Nanomedicine; 2020 Oct; 29():102278. PubMed ID: 32738299
[TBL] [Abstract][Full Text] [Related]
20. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
